Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Page values for "Mometasone"

From Pharmacopedia
More actions

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringMometasone furoate
brandStringNasonex (intranasal), Asmanex (inhaled), Elocon (topical), Sinuva (sinus implant); with formoterol as Dulera
structureFile
classesList of String, delimiter: ,[[:Category:Corticosteroids|Corticosteroid]] [[:Category:Glucocorticoids|Glucocorticoid]] [[:Category:Inhaled_corticosteroids|Inhaled corticosteroid (ICS)]]
mechanismString
usesString'"`UNIQ--vote-00000F98-QINU`"', '"`UNIQ--vote-00000F99-QINU`"', '"`UNIQ--vote-00000F9A-QINU`"', '"`UNIQ--vote-00000F9B-QINU`"'
starting_doseStringIntranasal Nasonex 2 sprays/nostril daily (50 mcg/spray); inhaled Asmanex 220 mcg DPI 1-2 inhalations daily/BID; topical Elocon 0.1% cream daily
preparationsStringNasonex 50 mcg/actuation intranasal; Asmanex HFA MDI 100/200 mcg; Asmanex Twisthaler DPI 110/220 mcg; Elocon 0.1% cream/ointment/lotion; Sinuva sinus implant; Dulera (with formoterol)
fda_maxStringIntranasal 200 mcg/d (adults); inhaled 880 mcg/d
pill_idText
routesList of String, delimiter: ,Intranasal inhaled topical intranasal sinus implant
onsetStringIntranasal: symptom relief 12-24 hours; inhaled: bronchial effect 1-2 weeks
durationString24 hours
halflifeString~5 hours (plasma)'"`UNIQ--ref-00000F9C-QINU`"'
bioavailabilityStringIntranasal: <1% systemic; inhaled lung deposition with extensive first-pass clearance'"`UNIQ--ref-00000F9D-QINU`"'
pregnancyStringIntranasal long considered acceptable; widely used in obstetric rhinitis.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalStringOTC (Nasonex 24HR) and [[USLegal:Prescription only|Rx-only]] (other forms) in US